Bupropion Dosage and Efficacy for Anxiety and Depression Management

Dosage and Administration

The American College of Physicians recommends taking the second daily dose of bupropion before 3 PM to minimize the risk of insomnia 1

The American College of Physicians suggests that bupropion is effective for the treatment of major depressive disorder, with efficacy comparable to other antidepressants 2
Bupropion is particularly effective for symptoms of apathy and lack of energy in depression, with a beneficial effect on dopamine levels 1

In patients with moderate to severe renal impairment, the total daily dose of bupropion should be reduced to 150 mg/day, as recommended by the National Institute of Diabetes and Digestive and Kidney Diseases 3
In patients with moderate to severe hepatic impairment, the total daily dose of bupropion should not exceed 150 mg, according to the National Institute of Diabetes and Digestive and Kidney Diseases 3
The American College of Physicians recommends evaluating the response to bupropion after 12 weeks of treatment, and considering a change in medication if the patient does not show significant improvement 2

The National Institute of Diabetes and Digestive and Kidney Diseases advises against using bupropion in patients with a history of seizure disorders, as it may lower the seizure threshold 3
Bupropion should not be administered to patients taking monoamine oxidase inhibitors (MAOIs) or within 14 days of discontinuing MAOIs, as recommended by the National Institute of Diabetes and Digestive and Kidney Diseases 3
Blood pressure should be monitored, especially at the start of treatment, according to the National Institute of Diabetes and Digestive and Kidney Diseases 3

The American Academy of Family Physicians recommends bupropion as an activating antidepressant that improves energy levels and reduces apathy through its effects on dopamine and norepinephrine reuptake, which can be beneficial for patients with depression and comorbid anxiety who also have prominent apathy, fatigue, or low energy 4
Bupropion is an appropriate choice for anxiety when it occurs as part of a depressive syndrome, particularly in patients with depression and anxiety who are also trying to quit smoking or reduce alcohol intake 4
Bupropion should be avoided in patients with conditions predisposing to seizures, including anorexia or bulimia nervosa, or abrupt discontinuation of alcohol, benzodiazepines, or antiepileptic drugs, as well as uncontrolled hypertension, which requires blood pressure monitoring, especially at treatment initiation 4

The American College of Physicians recommends assessing patient status within 1-2 weeks of bupropion initiation, monitoring for emergence of agitation, irritability, anxiety, or unusual behavioral changes, especially in patients with depression and comorbid anxiety 5
The American College of Physicians suggests selecting second-generation antidepressants, including bupropion, based on adverse effect profiles, cost, and patient preferences, as efficacy does not differ significantly, particularly for patients with comorbid depression and anxiety 5

The American College of Physicians recommends evaluating response to bupropion after 6-8 weeks; if inadequate, modify treatment rather than continuing ineffective therapy, to minimize anxiogenic effects in patients with depression and anxiety 5

Bupropion has lower rates of sexual adverse events compared to SSRIs, which may improve quality of life in patients with comorbid depression and anxiety, according to the American College of Physicians 5

The American Academy of Family Physicians recommends that bupropion should generally be avoided as a first‑line pharmacologic option for anxiety disorders, and it is specifically contraindicated in patients with agitated depression or prominent anxiety symptoms. 6
The American Academy of Family Physicians states that bupropion “should not be used in agitated patients” because of its activating properties. 6

When bupropion is prescribed, the second daily dose should be taken before 3 PM to minimize insomnia, which can exacerbate anxiety. 6

For individuals whose primary diagnosis is an anxiety disorder without comorbid depression, the guideline advises against using bupropion and recommends initiating an SSRI or SNRI instead. 7

In patients receiving bupropion for any indication, the incidence of seizures is approximately 0.1 %, highlighting the need to avoid the drug in individuals with seizure‑predisposing conditions (e.g., eating disorders, abrupt alcohol or benzodiazepine withdrawal)【8】.